ArticleEmerging microbes & infections2023

An engineered recombinant protein containing three structural domains in SARS-CoV-2 S2 protein has potential to act as a pan-human coronavirus entry inhibitor or vaccine antigen.

Xinling Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.